P. D. Minor

2.3k total citations
44 papers, 1.8k citations indexed

About

P. D. Minor is a scholar working on Cardiology and Cardiovascular Medicine, Infectious Diseases and Epidemiology. According to data from OpenAlex, P. D. Minor has authored 44 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Cardiology and Cardiovascular Medicine, 16 papers in Infectious Diseases and 12 papers in Epidemiology. Recurrent topics in P. D. Minor's work include Viral Infections and Immunology Research (24 papers), Viral gastroenteritis research and epidemiology (9 papers) and Virology and Viral Diseases (9 papers). P. D. Minor is often cited by papers focused on Viral Infections and Immunology Research (24 papers), Viral gastroenteritis research and epidemiology (9 papers) and Virology and Viral Diseases (9 papers). P. D. Minor collaborates with scholars based in United Kingdom, United States and Pakistan. P. D. Minor's co-authors include Jeffrey W. Almond, J. W. Almond, Michael A. J. Ferguson, D. M. A. Evans, Owen Jenkins, Joseph P. Icenogle, J. Saldanha, John D. Booth, P.A. Pipkin and Glyn Stanway and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and The EMBO Journal.

In The Last Decade

P. D. Minor

42 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P. D. Minor United Kingdom 18 1.2k 936 433 385 266 44 1.8k
Shudo Yamazaki Japan 27 475 0.4× 907 1.0× 348 0.8× 765 2.0× 436 1.6× 84 1.9k
David R. Kilpatrick United States 20 2.1k 1.8× 1.8k 1.9× 320 0.7× 782 2.0× 134 0.5× 33 2.4k
J. W. Almond United Kingdom 17 1.1k 0.9× 788 0.8× 485 1.1× 263 0.7× 156 0.6× 24 1.4k
Ignacio Mena United States 26 626 0.5× 888 0.9× 571 1.3× 1.1k 2.8× 288 1.1× 56 2.2k
Glynis Dunn United Kingdom 15 723 0.6× 669 0.7× 173 0.4× 164 0.4× 106 0.4× 17 1.1k
Fun-In Wang Taiwan 21 234 0.2× 536 0.6× 123 0.3× 152 0.4× 178 0.7× 72 1.3k
Kazuo Nishikawa Japan 18 202 0.2× 486 0.5× 132 0.3× 545 1.4× 261 1.0× 27 1.0k
Jean‐François Cantaloube France 24 161 0.1× 722 0.8× 130 0.3× 451 1.2× 320 1.2× 53 1.5k
Hiroko Minagawa Japan 24 396 0.3× 832 0.9× 180 0.4× 1.3k 3.4× 264 1.0× 68 1.9k

Countries citing papers authored by P. D. Minor

Since Specialization
Citations

This map shows the geographic impact of P. D. Minor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. D. Minor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. D. Minor more than expected).

Fields of papers citing papers by P. D. Minor

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. D. Minor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. D. Minor. The network helps show where P. D. Minor may publish in the future.

Co-authorship network of co-authors of P. D. Minor

This figure shows the co-authorship network connecting the top 25 collaborators of P. D. Minor. A scholar is included among the top collaborators of P. D. Minor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. D. Minor. P. D. Minor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cooper, Jillian K., et al.. (2011). Comparison of candidate vCJD in vitro diagnostic assays using identical sample sets. Vox Sanguinis. 102(2). 100–109. 7 indexed citations
2.
Cooper, Jillian K., et al.. (2007). Reference materials for the evaluation of pre‐mortem variant Creutzfeldt–Jakob disease diagnostic assays. Vox Sanguinis. 92(4). 302–310. 8 indexed citations
4.
Afzal, Muhammad & P. D. Minor. (2002). Vaccines, Crohn's disease and autism. Molecular Psychiatry. 7(S2). S49–S50. 6 indexed citations
5.
Minor, P. D.. (2002). Beyond HIV, HBV and HCV--how to deal with other viruses?. PubMed. 108. 15–9. 1 indexed citations
6.
Macadam, Andrew, et al.. (2001). Functional Formation of Domain V of the Poliovirus Noncoding Region: Significance of Unpaired Bases. Virology. 289(1). 45–53. 3 indexed citations
7.
Minor, P. D., G. Dunn, & P.A. Pipkin. (2001). Detection and growth kinetics of SV40 preparations with different enhancer element copy number. Vaccine. 19(25-26). 3467–3471. 3 indexed citations
8.
Minor, P. D.. (2001). Biosafety consequences of eradication of wild-type polioviruses. The Lancet. 358(9277). 166–168. 14 indexed citations
9.
Onions, David, David K.C. Cooper, Alexander T. Mikhailov, et al.. (2000). An approach to the control of disease transmission in pig‐to‐human xenotransplantation. Xenotransplantation. 7(2). 143–155. 96 indexed citations
10.
Afzal, Muhammad, P. D. Minor, & G. C. Schild. (2000). Clinical safety issues of measles, mumps and rubella vaccines.. PubMed. 78(2). 199–204. 24 indexed citations
11.
Minor, P. D.. (2000). The Challenge for the Public Health System. PubMed. 11. 151–159. 1 indexed citations
12.
Minor, P. D.. (1999). Inactivated influenza vaccines prepared in cell culture. Summary and recommendations.. PubMed. 98. 201–3. 1 indexed citations
13.
Pipkin, P.A. & P. D. Minor. (1998). Studies on the loss of infectivity of live type 3 poliovaccine on storage. Biologicals. 26(1). 17–23. 7 indexed citations
15.
McGoldrick, Adrian, Andrew Macadam, G. Dunn, et al.. (1995). Role of mutations G-480 and C-6203 in the attenuation phenotype of Sabin type 1 poliovirus. Journal of Virology. 69(12). 7601–7605. 53 indexed citations
16.
Macadam, Andrew, Stuart Pollard, G. Ferguson, et al.. (1993). Genetic Basis of Attenuation of the Sabin Type 2 Vaccine Strain of Poliovirus in Primates. Virology. 192(1). 18–26. 109 indexed citations
17.
Stone, David M., Karen L. Burke, Michael A. Skinner, et al.. (1993). Approaches to the construction of new candidate poliovirus type 3 vaccine strains.. PubMed. 78. 161–9; discussion 169. 1 indexed citations
18.
Minor, P. D.. (1992). The molecular biology of poliovaccines. Journal of General Virology. 73(12). 3065–3077. 148 indexed citations
19.
Turner, P., T Forsey, & P. D. Minor. (1991). Comparison of the nucleotide sequence of the SH gene and flanking regions of mumps vaccine virus (Urabe strain) grown on different substrates and isolated from vaccinees. Journal of General Virology. 72(2). 435–437. 17 indexed citations
20.
Ferguson, Michael A. J. & P. D. Minor. (1990). Differences in conformation of type 3 poliovirus antigenic sites on non-infectious empty particles and infectious virus. Journal of General Virology. 71(6). 1271–1274. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026